219 related articles for article (PubMed ID: 15226250)
1. Genetic markers: progress and potential for cardiovascular disease.
Gibbons GH; Liew CC; Goodarzi MO; Rotter JI; Hsueh WA; Siragy HM; Pratt R; Dzau VJ
Circulation; 2004 Jun; 109(25 Suppl 1):IV47-58. PubMed ID: 15226250
[No Abstract] [Full Text] [Related]
2. Genetics, genomics, proteomics: what is a cardiologist to do?
Califf RM
Am Heart J; 2000 Oct; 140(4):S48-50. PubMed ID: 11011324
[No Abstract] [Full Text] [Related]
3. Biomarkers of cardiovascular disease: molecular basis and practical considerations.
Vasan RS
Circulation; 2006 May; 113(19):2335-62. PubMed ID: 16702488
[No Abstract] [Full Text] [Related]
4. Molecular markers for cardiovascular disease: cardiovascular biomarkers to proteomic discovery.
Suzuki T; Nagai R
Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):295. PubMed ID: 18506210
[No Abstract] [Full Text] [Related]
5. Genetic and molecular markers for vascular disease. Overview.
Ballantyne CM
J Cardiovasc Risk; 1997; 4(5-6):321-3. PubMed ID: 9865661
[No Abstract] [Full Text] [Related]
6. Genomics of cardiovascular disease.
Manace LC; Godiwala TN; Babyatsky MW
Mt Sinai J Med; 2009 Dec; 76(6):613-23. PubMed ID: 20014425
[TBL] [Abstract][Full Text] [Related]
7. Molecular and genetic approaches to the study of cardiovascular disease.
Hallman DM; Ellsworth DL; Boerwinkle E
J Cardiovasc Risk; 1997; 4(5-6):325-31. PubMed ID: 9865662
[No Abstract] [Full Text] [Related]
8. [Genetic factors and the risk of cardiovascular diseases].
Teren A; Gavorník P
Vnitr Lek; 2007 Jun; 53(6):678-93. PubMed ID: 17702128
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in cardiovascular diseases: how can the "-omics" revolution be applicable at the bedside. Introduction.
Tang WH
Prog Cardiovasc Dis; 2012; 55(1):1-2. PubMed ID: 22824104
[No Abstract] [Full Text] [Related]
10. Genomics of cardiovascular disease.
O'Donnell CJ; Nabel EG
N Engl J Med; 2011 Dec; 365(22):2098-109. PubMed ID: 22129254
[No Abstract] [Full Text] [Related]
11. New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics.
Podgoreanu MV; Schwinn DA
J Am Coll Cardiol; 2005 Dec; 46(11):1965-77. PubMed ID: 16325027
[TBL] [Abstract][Full Text] [Related]
12. Gaining insights in coronary disease genomics.
Murray SS; Topol EJ
J Am Coll Cardiol; 2008 Jul; 52(5):385-6. PubMed ID: 18652947
[No Abstract] [Full Text] [Related]
13. The Editor's Roundtable: Endothelial dysfunction in cardiovascular disease.
Friedewald VE; Giles TD; Pool JL; Yancy CW; Roberts WC
Am J Cardiol; 2008 Aug; 102(4):418-23. PubMed ID: 18678298
[No Abstract] [Full Text] [Related]
14. Assessment of cardiovascular risk: time to apply genetic risk factors?
Muntwyler J; Lüscher TF
Eur Heart J; 2000 Apr; 21(8):611-3. PubMed ID: 10731398
[No Abstract] [Full Text] [Related]
15. Genomics and proteomics methodologies for vulnerable populations research.
Kasper CE
Annu Rev Nurs Res; 2007; 25():191-217. PubMed ID: 17958293
[TBL] [Abstract][Full Text] [Related]
16. Prospects for personalized cardiovascular medicine: the impact of genomics.
Ginsburg GS; Donahue MP; Newby LK
J Am Coll Cardiol; 2005 Nov; 46(9):1615-27. PubMed ID: 16256859
[TBL] [Abstract][Full Text] [Related]
17. [Cardiovascular diseases: present and future based on molecular biology].
Oseguera Moguel J
Rev Invest Clin; 2003; 55(2):155-60. PubMed ID: 12827919
[No Abstract] [Full Text] [Related]
18. Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases.
López-Pedrera C; Barbarroja N; Aguirre MA; Torres LA; Velasco F; Cuadrado MJ
Lupus; 2008 Oct; 17(10):904-15. PubMed ID: 18827055
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis for common complex disease.
Hauser ER; Pericak-Vance MA
Am Heart J; 2000 Oct; 140(4):S36-44. PubMed ID: 11011322
[No Abstract] [Full Text] [Related]
20. Biological ageing and cardiovascular disease.
Samani NJ; van der Harst P
Heart; 2008 May; 94(5):537-9. PubMed ID: 18411343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
